NASDAQ$HCM
HUTCHMED China Limited · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Headline financials
Revenue & EPS history
HUTCHMED · Revenue · Quarterly
$76.1M
Q2 2021-28.7%vs Q2 2020
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-1.4%
Avg return
Earnings day
+1.1%
Avg return
5 days after
-2.0%
Avg return
30 days after
38%
11 / 29 earnings
Positive
+13.0%
Q4 2015
Best reaction
-17.6%
Q1 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2024 | +2.7% | +1.8% | -2.9% | |
| Q4 2023 | -5.5% | -6.1% | -13.5% | |
| Q2 2023 | +3.1% | +12.0% | +7.7% | |
| Q1 2023 | +9.1% | +10.9% | -14.7% | |
| Q4 2022 | +9.1% | +10.9% | -14.7% | |
| Q2 2022 | -9.0% | +6.2% | -1.6% | |
| Q4 2021 | -17.6% | -30.8% | -24.4% | |
| Q1 2022 | -17.6% | -30.8% | -24.4% | |
| Q2 2021 | +12.4% | +17.4% | +2.7% | |
| Q1 2021 | -2.0% | -0.6% | +0.8% | |
| Q4 2020 | +1.3% | -7.1% | -8.4% | |
| Q2 2020 | -2.6% | +7.6% | +21.0% | |
| Q1 2020 | -3.1% | +7.3% | +16.4% | |
| Q3 2019 | -12.6% | -19.7% | -26.0% | |
| Q4 2019 | +2.0% | +0.0% | -28.3% | |
| Q3 2018 | -12.6% | -20.2% | -6.7% | |
| Q2 2019 | +1.2% | +8.6% | +28.6% | |
| Q1 2019 | -5.1% | -3.2% | -19.7% | |
| Q1 2018 | -5.1% | -3.2% | -19.7% | |
| Q4 2018 | +4.5% | +3.8% | +17.1% | |
| Q2 2018 | -4.8% | -2.2% | -15.9% | |
| Q4 2014 | -2.7% | -8.0% | -14.5% | |
| Q4 2017 | -2.7% | -8.0% | -14.5% | |
| Q3 2017 | -2.3% | +6.4% | +6.9% | |
| Q2 2017 | -2.3% | +6.4% | +6.9% | |
| Q2 2016 | -2.3% | +6.4% | +6.9% | |
| Q4 2016 | +13.0% | +34.2% | +41.2% | |
| Q4 2015 | +13.0% | +34.2% | +41.2% | |
| Q3 2016 | -1.4% | -1.2% | -5.6% | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro